Myths vs facts: CYP2D6 and stress

The claim that your CYP2D6 genotype directly determines how you handle stress is largely a myth. CYP2D6 is a liver enzyme primarily responsible for metabolizing about 20–25% of all prescription drugs, including many antidepressants and beta-blockers used for anxiety. There is some mechanistic evidence that CYP2D6 may also influence the metabolism of endogenous neurotransmitters like serotonin and dopamine, which are involved in mood and stress regulation. However, direct evidence linking common CYP2D6 variants (poor, intermediate, extensive, or ultrarapid metabolizer status) to physiological stress markers such as cortisol or heart rate variability in healthy individuals is weak and inconsistent. Most research focuses on drug response, not on stress resilience per se. Consumer pharmacogenetic tests often overstate these connections for marketing purposes. The reality: stress is a complex interplay of environment, psychology, and many genes. A CYP2D6 test cannot predict your stress level or tell you how to manage it. Evidence-based stress management (exercise, sleep, social support) remains far more impactful than any single genetic variant.